News
>> Leadership >> Partnerships >> News

Ativa Medical is ahead of the industry and in the news -- visit this page to stay on top of our latest product developments, events, and partnerships.

 


 August 23, 2016: Ativa Invited speaker at Nex Gen Dx Summit in Washington DC

Micro Flow Cytometry: Automated Sample Prep Enabling A Broad POC Menus 

Dan McPeak, Ph.D., Director, Microfluidics, Ativa Medical

The clinical value of high-volume tests, such as CBC, is enhanced when coupled with commonly co-ordered, lower-volume assays. With a broad menu of tests available, POC practitioners would be better equipped to complete a diagnosis within the span of patient contact. This presentation discusses how Ativa Medicalís CBC technology creates opportunities for lower-volume, high-value cytometry assays at the point-of-care.

http://www.nextgenerationdx.com/point-of-care-diagnostics/

 July 31, 2016: Ativa at AACC in Philadelphia 7/31-8/4, 2016
 
 March 14, 2016: MHTA > SciTechsperience Interns Hope to Change Lives at Ativa Medical
MHTA, or the Minnesota High Technology Association honors two of Ativa's employees:

SciTechsperience Interns Hope to Change Lives at Ativa Medical

MHTA - MHTA staff recently visited Ativa Medical in Saint Paul to meet the company's current SciTechsperience interns, Aschalew Chamiso and Erin Duffy. Ativa is making waves in the healthcare industry for it's novel point-of-care diagnostics product that allows physicians to easily take comprehensive blood-based tests. Rather than sending samples to a lab and waiting days for the results, physicians can use Ativa's "tabletop micro lab" on-site (the size of a small desktop computer) to get results in minutes.
 March 13, 2016: Ativa Medical Presenting at the 28th Annual Roth Conference
 Ativa Medical Presenting at the 28th Annual Roth Conference, in Dana Point California.  

Overview
ROTH Capital Partners invites you to join us for our 28th Annual Conference. This conference is one of the largest of its kind in the U.S. Following the success of previous years' events, the ROTH Conference, with over 500 participating companies and over 3,000 attendees, will feature presentations from hundreds of public and private companies in a variety of sectors including:
  • Business Services

  • Cleantech & Solar

  • Consumer

  • Industrial Growth

  • Healthcare

  • Resources

  • Retail & E-Commerce

  • Technology & Media


    More


Analyzer and Test Cards
How it works
Features/Benefits
Ativa Leadership
Ativa Partnerships
Ativa News
Terms and Conditions
Privacy
Ativa Medical Corporation
1000 Westgate Drive, Suite 100
St. Paul, Minnesota 55114 612.293.3993 Direct
© Ativa Medical Corporation 2017 All rights Reserved
 
This device has not been evaluated, cleared or approved for use by the FDA, and is not for sale in the US. Safety and effectiveness have not been established.


All statements that address expectations or projections about the future, including statements about product development, market position, and financial results, are forward-looking statements. Forward-looking statements can be identified by words like "expect," "may," "could," "believe," "would," "might," "anticipates," and similar expressions. Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. We undertake no obligation to update any forward-looking statements.